A Europe-wide strategy to enhance transplantation of highly sensitized patients on basis of Acceptable HLA mismatches

EUROSTAM is a project financed by the EC (FP7-HEALTH Collaborative project). The project started on 1 december 2012 and will last for three years.

The project adresses the FP7 workprogramme topic: Innovative approaches to solid organ transplantation.
Main aim of the project is to determine the feasibility and advantage to implement a Europe-wide acceptable mismatch program to facilitate transplantation of highly sensitized patients, who do not have a chance to be transplanted in their own population. The simulation studies on basis of the HLA phenotypes in different European populations will show the theoretical advantage of a Europe-wide acceptable mismatch program. The results of these studies will be published on the EUROSTAM website and in an international peer reviewed journal.

Our goal:

The major objective of the 10 partners in this project is to analyze the feasibility and requirements for a Europe-wide acceptable mismatch program to enhance transplantation of patients with rare HLA phenotypes in their own population. Read more ….

Consortium Meeting – Nov 2015

On 19-20 November 2015, the last consortium meeting of the EUROSTAM project has taken place at  the Regentenkamer in Leiden. On November 19th the meeting started at 14:00 (CET) after lunch at "The Baroness of Leyden". On the second day, at Golden Tulip & Tulip...

read more

Workshop – Nov 2015

on 17-19 November 2015, there will be a workshop organised at Golden Tulip & Tulip Inn Hotel in Leiden. We will start with a welcome diner in the evening of November 17. On November 18, we will have a day with presentations on the current status of the definition...

read more


The project has received funding from the European Union’s Seventh Framework Programme [FP7/2007-2013] under grant agreement number HEALTH-F4-2012-305385